Author:
Groheux David,Hindié Elif
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference16 articles.
1. García Vicente A, Soriano Castrejón Á, López-Fidalgo J, Amo-Salas M, del Muñoz Sánchez M, Álvarez M, et al. Basal 18F-FDG PET/CT as a prognostic biomarker in patients with locally advanced breast cancer. Eur J Nucl Med Mol Imaging. 2015. doi: 10.1007/s00259-015-3102-x .
2. NCCN. Clinical Practice Guidelines in Oncology: breast cancer, version 2. Fort Washington, PA: National Comprehensive Cancer Network; 2015. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp .
3. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.
4. Cochet A, Dygai-Cochet I, Riedinger J-M, Humbert O, Berriolo-Riedinger A, Toubeau M, et al. 18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations. Eur J Nucl Med Mol Imaging. 2014;41:428–37.
5. Groheux D, Hindié E, Delord M, Giacchetti S, Hamy A-S, de Bazelaire C, et al. Prognostic impact of 18FDG-PET-CT findings in clinical stage III and IIB breast cancer. J Natl Cancer Inst. 2012;104:1879–87.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献